A Randomized, Placebo-Controlled Crossover Trial of Extended Release Guanfacine for the Treatment of ADHD and Cognitive Deficits in Children and Adolescents with NF1

PROTOCOL CHAIRS

• Jonathan M. Payne, BSc (Hons), DPsych (Neuro), Chair
• David Coghill, MD, Co-Chair
• Nicole Ullrich, MD, PhD, Co-Chair
• Karin S. Walsh, PsyD, Co-Chair